PharmGKB summary: very important pharmacogene information for CYP3A5
J Lamba, JM Hebert, EG Schuetz… - Pharmacogenetics …, 2012 - journals.lww.com
The aim of a PharmGKB VIP summary is to provide a simple overview of a gene with respect
to drug effects. In some cases, there may be extensive evidence of variants that have known …
to drug effects. In some cases, there may be extensive evidence of variants that have known …
[PDF][PDF] PharmGKB summary: very important pharmacogene information for CYP3A5
J Lambaa, JM Hebertb, EG Schuetzd… - Pharmacogenet …, 2012 - gbcbiotech.com
The aim of a PharmGKB VIP summary is to provide a simple overview of a gene with respect
to drug effects. In some cases, there may be extensive evidence of variants that have known …
to drug effects. In some cases, there may be extensive evidence of variants that have known …
PharmGKB summary: very important pharmacogene information for CYP3A5.
J Lamba, JM Hebert, EG Schuetz, TE Klein… - Pharmacogenetics …, 2012 - europepmc.org
The aim of a PharmGKB VIP summary is to provide a simple overview of a gene with respect
to drug effects. In some cases, there may be extensive evidence of variants that have known …
to drug effects. In some cases, there may be extensive evidence of variants that have known …
[引用][C] PharmGKB summary
J Lamba, JM Hebert, EG Schuetz, TE Klein… - Pharmacogenetics and …, 2012 - cir.nii.ac.jp
PharmGKB summary | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ]
詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
[引用][C] PharmGKB summary: very important pharmacogene information for CYP3A5
J Lamba, JM Hebert, EG Schuetz… - Pharmacogenetics …, 2012 - pubmed.ncbi.nlm.nih.gov
[HTML][HTML] PharmGKB summary: very important pharmacogene information for CYP3A5
J Lamba, JM Hebert, EG Schuetz, TE Klein… - Pharmacogenetics …, 2012 - ncbi.nlm.nih.gov
The aim of a PharmGKB VIP summary is to provide a simple overview of a gene with respect
to drug effects. In some cases, there may be extensive evidence of variants that have known …
to drug effects. In some cases, there may be extensive evidence of variants that have known …
[引用][C] PharmGKB summary: very important pharmacogene information for CYP3A5
J LAMBA, JM HEBERT, EG SCHUETZ… - … and genomics (Print …, 2012 - pascal-francis.inist.fr
PharmGKB summary: very important pharmacogene information for CYP3A5 CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
PharmGKB summary: very important pharmacogene information for CYP3A5.
J Lamba, JM Hebert, EG Schuetz, TE Klein… - Pharmacogenetics …, 2012 - europepmc.org
The aim of a PharmGKB VIP summary is to provide a simple overview of a gene with respect
to drug effects. In some cases, there may be extensive evidence of variants that have known …
to drug effects. In some cases, there may be extensive evidence of variants that have known …